Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,15 USD | +1,67% | -6,63% | +19,14% |
23/04 | ASTRIA THERAPEUTICS, INC. : HC Wainwright herhaalt koopadvies | ZM |
09/04 | Astria Therapeutics, Inc. benoemt Sunil Agarwal in zijn raad van bestuur | CI |
Vakgebied
Aantal werknemers: 59
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26-06-08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01-04-11 |
Chief Tech/Sci/R&D Officer | - | 15-07-22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17-07-23 |
Keri McGrail
HRO | Human Resources Officer | - | 01-03-21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25-09-19 |
Ben Harshbarger
LAW | General Counsel | 55 | 12-06-20 |
Andrea Matthews
PRN | Corporate Officer/Principal | - | 01-07-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01-01-14 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04-01-19 |
Director/Board Member | 75 | 05-04-16 | |
Jonathan Violin
BRD | Director/Board Member | 49 | 28-01-21 |
Jill Milne
FOU | Founder | 56 | 26-06-08 |
Hugh Cole
BRD | Director/Board Member | 59 | 26-07-19 |
Joanne Beck
BRD | Director/Board Member | 63 | 14-02-19 |
Director/Board Member | 56 | 28-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 913 061 | 48 159 943 ( 87,70 %) | 0 | 87,70 % |
Aandeel B | 0 | 31 107 | 0 | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,14% | 502 mln. | |
-2,63% | 102 mld. | |
+1,62% | 96,29 mld. | |
+2,47% | 22,18 mld. | |
-16,67% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-38,74% | 17,38 mld. | |
-13,21% | 16,36 mld. | |
+5,41% | 13,97 mld. | |
+33,57% | 12,17 mld. |
- Beurs
- Aandelen
- Koers ATXS
- Onderneming Astria Therapeutics, Inc.